Evidence map›Paper›PMID 39158462›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

Hispanic/Latino Ethnicity Is an Independent Predictor of Worse Survival for Gastric Cancer in a Multicenter Safety-Net Patient Population.

Kyle D Klingbeil, Dustin L Dillon, Erfan Zarrinkhoo, Kirollos Bechay, Joon Y Park, Jordan M Rook, Michael A Mederos, Mark D Girgis, Keren Chen, Kuan-Ting Chen and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Kyle D KlingbeilDivision of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0002-4359-5556
Dustin L DillonUCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0002-9272-4481
Erfan ZarrinkhooDepartment of Internal Medicine, UCLA-Olive View, Sylmar, California.ORCID 0009-0006-5424-1899
Kirollos BechayUCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0002-8897-2431
Joon Y ParkDivision of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0002-3847-9198
Jordan M RookDivision of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0003-3579-4704
Michael A MederosDivision of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0001-8098-7746
Mark D GirgisDivision of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0002-8085-4422
Keren ChenDepartment of Medicine, Statistics Core, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0009-0003-6309-127X
Kuan-Ting ChenDepartment of Medicine, Statistics Core, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0009-0002-0904-4440
Roshan BastaniJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0001-6594-9231
Shawdi Manouchehr-PourDepartment of Radiology, UCLA-Olive View, Sylmar, California.ORCID 0009-0009-1879-5677
Priyanka DubéDepartment of Radiology, UCLA-Olive View, Sylmar, California.ORCID 0000-0002-5973-1014
Karoly ViraghDepartment of Radiology, UCLA-Olive View, Sylmar, California.ORCID 0000-0002-0139-2507
Mariam ThomasDepartment of Radiology, UCLA-Olive View, Sylmar, California.ORCID 0000-0002-3936-1108
Victor ChiuIronwood Cancer and Research Centers, Chandler, Arizona.ORCID 0009-0004-7641-9366
Brian E KaderaDivision of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0002-5133-8656

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
National Center for Advancing Translational Sciences (NCATS) UL1TR001881NCATS NIH HHS UL1 TR001881UCLA Department of Surgery
6 · The paper itself

Abstract

backgroundVarious population-based studies have shown Hispanic/Latino ethnicity is a risk factor for worse survival in patients with gastric cancer linked to disparate access to care. We aimed to address whether Hispanic patients treated within safety-net hospital systems continue to experience this survival deficit compared to non-Hispanic patients.

methodsWe performed a retrospective cohort study comparing survival between Hispanic and non-Hispanic patients diagnosed with gastric adenocarcinoma between January 1, 2016, and December 31, 2020, within Los Angeles County's safety-net hospital system. Gastric cancer-specific survival was compared between the two cohorts using the Kaplan-Meier estimate and Cox proportional-hazards regression model.

resultsIn total, 448 patients who received care from five medical centers were included; 348 (77.7%) patients self-identified as Hispanic and 100 (22.3%) as non-Hispanic. Mean follow-up time was 2.0 years (median 0.91 years, IQR, 0.34-2.5 years). Hispanic patients were found to be diagnosed at a younger age (55.6 vs. 60.7 years, P < 0.01), demonstrate higher state area deprivation index (6.4 vs. 5.0, P < 0.01), and present with metastatic disease (59.8% vs. 45%, P = 0.04). After adjusting social and oncologic variables, Hispanic ethnicity remained an independent risk factor for worse survival [HR 1.56, (95% CI, 1.06-2.28); P = 0.02].

conclusionsHispanic patients treated within a large, multicenter safety-net hospital system experience worse survival compared to non-Hispanic patients. This suggests ethnic disparities exist within safety-net hospital systems, independent of known clinicopathologic factors. IMPACT: Improving outcomes for Hispanic patients with gastric cancer requires future efforts aimed at defining and addressing these unidentified barriers to care. See related In the Spotlight, p. 12.

Indexed as

Hispanic or LatinoSafety-net ProvidersStomach NeoplasmsAdenocarcinomaAgedFemaleHumansLos AngelesMaleMiddle AgedRetrospective StudiesRisk Factors

Identifiers

PMID39158462
PMCPMC11717642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.